3506 results for «2028»

Filter By

3506 results

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

15 May 2024 – From EuroPCR 2024

Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

Case closed: understanding the steps of vascular access and closure in TAVI patients

14 May 2024 – From EuroPCR 2024

Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...

Case closed: understanding the steps of vascular access and closure in TAVI patients

Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy

In this session featuring a LIVE case demonstration from Madrid, Spain, gain insights into identifying calcified lesions requiring plaque modification, effectively guiding lesion treatment with OCT support, and correctly applying orbital atherectomy, while sharing experiential knowledge step by step.

Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy

Contemporary TAVI: the VISION of lifetime management

15 May 2024 – From EuroPCR 2024

In this session, discover how pre-procedural assessment is used to optimize procedural outcomes, ensuring the best possible results for patients undergoing TAVI, learn the intricacies of selecting the most suitable valve for each individual patient, considering their unique anatomical and clinical factors, and engage in discussions...

Contemporary TAVI: the VISION of lifetime management

How does the female heart respond to severe aortic stenosis and aortic intervention?

15 May 2024 – From EuroPCR 2024

In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...

How does the female heart

The complexity in treatment of patients in shock

16 May 2024 – From EuroPCR 2024

This session is essential for those looking to analyze and discuss the findings of the DanGer shock randomized trial, explore the latest evidence in the ACS field such as Horizon, and implement evidence-based practices in peri-procedural planning, execution, drug administration, and weaning strategies to optimize outcomes...

The complexity in treatment of patients in shock

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

14 May 2024 – From EuroPCR 2024

Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence

15 May 2024 – From EuroPCR 2024

In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...

A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

15 May 2024 – From EuroPCR 2024

Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

Second generation biolimus drug-coated balloon in clinical practice

15 May 2024 – From EuroPCR 2024

Discover the potential applications of the new biolimus-coated balloon in treating de novo large vessel lesions, explore its effectiveness in addressing ISR based on findings from the BIO ASCEND ISR study, and uncover insights into the safety and feasibility of BA9 DCB in treating small vessel,...

Second generation biolimus drug-coated balloon in clinical practice

The future of interventional cardiology imaging

15 May 2024 – From EuroPCR 2024

Explore this session to discover the latest innovations in interventional cardiology images, including the benefits of artificial intelligence and angio-CT in PCI/SHD procedures. Learn about Alphenix Evolve and the initial experiences with AI imaging in daily cathlab practice, alongside intraprocedural angio-CT guided LAAO, and engage in...

The future of interventional cardiology imaging

PCI in patients with diabetes: next generation DES + DCB stent platform in action

14 May 2024 – From EuroPCR 2024

Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...

PCI in patients with diabetes: next generation DES + DCB stent platform in action

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

16 May 2024 – From EuroPCR 2024

Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...

Sirolimus-coated balloon: exploring the case- and clinical-based evidences

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

15 May 2024 – From EuroPCR 2024

Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...

Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions

Identification and treatment of (sub)clinical transcatheter valve thrombosis

16 May 2024 – From EuroPCR 2024

This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...

Identification and treatment of (sub)clinical transcatheter valve thrombosis

TAVI in TAVI - LIVE case

14 May 2024 – From EuroPCR 2024

A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...

TAVI for degenerated aortic bioprosthesis

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy

15 May 2024 – From EuroPCR 2024

Follow this session to learn about the novel HC-IVL system, its application for moderate to severe calcified lesions, and procedural tips. The LithiX Hertz Contact IVL addresses unmet needs in coronary artery calcification by offering a simplified workflow with fewer devices and effective treatment for difficult...

Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy

STEMI: thrombus is the problem

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the management of STEMI patients with a high thrombotic burden. Attendees will have the opportunity to explore various strategies and techniques, such as the use of pharmacomechanical thromboaspiration, prevention of...

STEMI: thrombus is the problem
Didn’t find what you were looking for?